Parkinson's disease α-synuclein mutations exhibit defective axonal transport in cultured neurons

AR Saha, J Hill, MA Utton, AA Asuni… - Journal of cell …, 2004 - journals.biologists.com
AR Saha, J Hill, MA Utton, AA Asuni, S Ackerley, AJ Grierson, CC Miller, AM Davies…
Journal of cell science, 2004journals.biologists.com
α-Synuclein is a major protein constituent of Lewy bodies and mutations in α-synuclein
cause familial autosomal dominant Parkinson's disease. One explanation for the formation
of perikaryal and neuritic aggregates of α-synuclein, which is a presynaptic protein, is that
the mutations disrupt α-synuclein transport and lead to its proximal accumulation. We found
that mutant forms of α-synuclein, either associated with Parkinson's disease (A30P or A53T)
or mimicking defined serine, but not tyrosine, phosphorylation states exhibit reduced axonal …
α-Synuclein is a major protein constituent of Lewy bodies and mutations in α-synuclein cause familial autosomal dominant Parkinson's disease. One explanation for the formation of perikaryal and neuritic aggregates of α-synuclein, which is a presynaptic protein, is that the mutations disrupt α-synuclein transport and lead to its proximal accumulation. We found that mutant forms of α-synuclein, either associated with Parkinson's disease (A30P or A53T) or mimicking defined serine, but not tyrosine, phosphorylation states exhibit reduced axonal transport following transfection into cultured neurons. Furthermore, transfection of A30P, but not wild-type, α-synuclein results in accumulation of the protein proximal to the cell body. We propose that the reduced axonal transport exhibited by the Parkinson's disease-associated α-synuclein mutants examined in this study might contribute to perikaryal accumulation of α-synuclein and hence Lewy body formation and neuritic abnormalities in diseased brain.
journals.biologists.com